Secukinumab

Recombinant monoclonal antibody to IL17A. Secukinumab is a human monoclonal antibody designed for the treatments of uveitis, rheumatoid arthritis, and psoriasis. It targets member A from the cytokine family of interleukin 17.

Target

IL17A

Type

IgG1 - kappa

Immunogen

HuIL-17 coupled 10 KLH mixed 1:1 with huIL-17 in Gerbu adjuvant.

Species Reactivity

Human

Expression Host

CHO

Applications

Suitable for use in IF, IP, Neut, FuncS, ELISA, FC, ICC and most other immunological methods.